The result showed that CPEB4 had stronger immunoreactive staining in recurrent tumors than that of primary tumors (Figure 1D, left), and semi-quantification using H-score analysis proved the higher expression level of CPEB4 in recurrent ovarian tumors (Figure 1D, right). Here, CPEB4 is linked to ovarian neoplasm.